Log in to save to my catalogue

Association of risk of incident acne and treatment with systemic Janus kinase inhibitors in atopic d...

Association of risk of incident acne and treatment with systemic Janus kinase inhibitors in atopic d...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2869780723

Association of risk of incident acne and treatment with systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and meta-analysis

About this item

Full title

Association of risk of incident acne and treatment with systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and meta-analysis

Publisher

Cham: Springer International Publishing

Journal title

Inflammation research, 2023-09, Vol.72 (9), p.1861-1871

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Introduction
The therapeutic efficacy of systemic Janus kinase (JAK) inhibitors in moderate-to-severe atopic dermatitis (AD) is well established. However, the associated risk of incident acne, which is a prevalent adverse event in AD patients treated with systemic JAK inhibitors, has yet to be systematically analyzed.
Methodology
To evalua...

Alternative Titles

Full title

Association of risk of incident acne and treatment with systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and meta-analysis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2869780723

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2869780723

Other Identifiers

ISSN

1023-3830,1420-908X

E-ISSN

1420-908X

DOI

10.1007/s00011-023-01789-x

How to access this item